openPR Logo
Press release

$57.5 Billion Vaccines Market - 2025, Leading players Sanofi Pasteur, Merck, AstraZeneca, Pfizer, Johnson & Johnson, Takeda, GlaxoSmithKline Pharma GmbH, Johnson & Johnson, Daiichi Sankyo, Inc., Takeda, CSL, Emergent BioSolutions

01-14-2019 12:15 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Meticulous Research

$57.5 Billion Vaccines Market - 2025, Leading players Sanofi

Vaccines represent one of the greatest achievements of science and medicine in the fight against infectious diseases. Vaccination is one of the most cost-effective public health tools to prevent infectious diseases. Significant progress has been made in expanding the coverage of vaccines globally, resulting in the prevention of more than two million deaths annually. Meticulous Research® in its latest publication on vaccines market states that the global vaccines market will increase at a CAGR of 7.9% from 2018 to 2025 to reach USD 57,501.8 million by 2025.

The growth of the global vaccines market is mainly attributed to high prevalence of diseases, increasing government initiatives towards immunization, rising adoption of vaccines, technological advancement in vaccine industry, and strong pipeline for vaccines. Furthermore, the increasing epidemic potentials and growing focus on therapeutic vaccines are expected to offer significant growth opportunities for players operating in the vaccines market.

To provide efficient analysis, Meticulous Research has segmented this market on the basis of indication (pneumococcal, influenza, DTP, HPV, hepatitis, meningococcal, rotavirus, polio, MMR), type (live, toxoid), route of administration (IM, SC, oral), valence (monovalent, multivalent), and geography.

Browse research study here: https://www.meticulousresearch.com/product/vaccines-market/

Top players analysed here are:
Sanofi Pasteur
Merck
GlaxoSmithKline Pharma GmbH
Pfizer
Johnson & Johnson
Daiichi Sankyo, Inc.
Takeda
CSL
Emergent BioSolutions
AstraZeneca

Wherein, geographically, North America commanded the largest share in this market followed by Europe. The major share of North America is mainly attributed to its well established vaccination programs, increasing prevalence of diseases, growing adoption of advanced vaccines, and large pool of key players.

While in terms of indication, pneumococcal disease accounted for the largest share in the global vaccines market in 2017. The large share of this segment is mainly attributed to high prevalence of pneumococcal disease in pediatric, elderly, and immune compromised populations. In addition, growing number of pneumococcal diseases resulting in chronic illnesses is further driving the adoption of the pneumococcal vaccines globally.

Vaccines Market by Indication (Pneumococcal, Influenza, DTP, HPV, Hepatitis, Meningococcal, Rotavirus, Polio, MMR), Type (Live, Toxoid), Route of Administration (IM, SC, Oral), Valence (Monovalent, Multivalent) And Geography – Global Forecast To 2025

Download free sample report here : https://www.meticulousresearch.com/download-sample-report/?cp_id=4813

About Meticulous Research®

Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.

Contact us :
Viren Shrivastava
AVP- Global Sales and Marketing
Meticulous Research®
Email: viren@meticulousresearch.com
Direct Lines: +1-646-781-8004 (North America)
+44-203-868-8738 (Europe)
+91 744-7780008 (Asia-Pacific)
Office No-402, 4th Floor, Pushpak Business Hub, Wakad, Pune-411057

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release $57.5 Billion Vaccines Market - 2025, Leading players Sanofi Pasteur, Merck, AstraZeneca, Pfizer, Johnson & Johnson, Takeda, GlaxoSmithKline Pharma GmbH, Johnson & Johnson, Daiichi Sankyo, Inc., Takeda, CSL, Emergent BioSolutions here

News-ID: 1494270 • Views:

More Releases from Meticulous Research

Southeast Asia Galvanized Steel Market Worth $24.21 Billion by 2028
According to a new market research report titled "Southeast Asia Galvanized Steel Market by Product Type (Hot-dipped Galvanized Steel, Electro-galvanized Steel); Application (Building and Construction, Automotive, White Goods, Shipbuilding, Other Applications); and Country - Forecast to 2028," published by Meticulous Research®, the Southeast Asia galvanized steel market is expected to grow at a CAGR of 13% from 2021 to 2028 to reach $24.21 billion by 2028. By volume, this market
Direct-to-Consumer (DTC) Pet Food Market Worth $8.16 Billion by 2028
Direct-to-Consumer (DTC) Pet Food Market Worth $8.16 Billion by 2028
According to a new market research report titled "Direct to Consumer Pet Food Market by Type (Meal [Standard, Customized], Treats, Supplements), Pet Type (Dogs, Cats), Health Condition (Nutrition), Distribution Channel (Online, Offline), and Geography - Global Forecasts to 2028", published by Meticulous Research®, the DTC pet food market is expected to grow at a CAGR of 25.2% from 2021-2028 to reach $8.16 billion by 2028. Download Free Sample Report Now @
Nut Ingredients Market to Reach $10.2 Billion by 2030
Nut Ingredients Market to Reach $10.2 Billion by 2030
Meticulous Research®-a leading global market research company, published a research report titled, 'Nut Ingredients Market by Type (Almond, Cashew, Walnut, Hazelnut, Others), Form (Roasted, Raw, Powdered, Cut), Application (Confectionary, Snacks & Bars, Dairy Products, Beverages, Bakery Products), and Geography - Global Forecast to 2030.' According to this latest publication from Meticulous Research®, the global nut ingredients market is projected to reach $10.2 billion by 2030, at a CAGR of 6.1% from
Wireless Electric Vehicle Charging Systems Market to be Worth $2.5 Billion by 2030
Wireless Electric Vehicle Charging Systems Market to be Worth $2.5 Billion by 20 …
According to a new market research report titled, 'Wireless Electric Vehicle Charging Systems Market by Type (Dynamic, Static), Component (Base Pads, Vehicle Pads), Technology, Application, Vehicle Type (BEV, PHEV), Power Supply, End User, Distribution Channel and Geography-Global Forecasts to 2030', the wireless EV charging systems market is projected to reach $2.5 billion by 2030, at a CAGR of 50.1% from 2023 to 2030. Wireless electric vehicle charging systems are charging systems

All 5 Releases


More Releases for Vaccines

Vaccines Market: Information by Type (Monovalent Vaccines, Multivalent Vaccines) …
Till date, vaccines have majorly contributed to eradicating several severe diseases—smallpox and polio—from the face of the earth. During 1980–90, around millions of people died due to smallpox. Moreover, after the introduction of a worldwide End Polio Campaign, the number of polio cases has reduced to 407 in 2013 from 350,000 in 1988, the CDC. Global vaccines market was valued at USD 30.2 billion in 2018 and is expected to
Global Pet Vaccine Market By Type (Attenuated Live Vaccines, Conjugate Vaccines, …
The Global Pet Vaccine Market 2020 report implement in-depth research of the industry with a focus on the current market trends future prospects. The Global Pet Vaccine Market report aims to provide an overview of Pet Vaccine Market players with detailed market segmentation by product, application and geographical region. It also provides market share and size, revenue forecast, growth opportunity. The most recent trending report Worldwide Pet Vaccine Market Economy
Animal Vaccines Market Report 2018: Segmentation by Product (Attenuated Vaccines …
Global Animal Vaccines market research report provides company profile for Merck & Co., Inc., Zoetis Inc., Ceva Sant Animale, Sanofi S.A., Romvac, Vaxxinova, Biovac, Merial, Anicon Labor GmbH, Nexvet, PHL Associates, Inc., Hygieia Biological Laboratories, Colorado Serum Company, Pfizer, Arko Laboratories, Ltd. Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in
Vaccines & Vaccination Market Report 2018: Segmentation by Type (Subunit vaccine …
Global Vaccines & Vaccination market research report provides company profile for CSL, Emergent BioSolutions, GSK, Johnson & Johnson, Pfizer, Merck, Sanofi, Abbott, AstraZeneca, Bavarian Nordic, Novartis, Bharat Biotech, Bio-Med and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year
Global Veterinary Vaccines Market by Type - Livestock Vaccines and Companion Vac …
According to the report Global Veterinary Vaccines market, published by Market Data Forecast, The Global market has been estimated at USD 5507.3 Million in 2015 and is projected to reach USD 7197.82 Million by 2020, at a CAGR of 5.5% during the forecast period from 2015 to 2020. The Global veterinary vaccines market has seen significant growth over the past few years, due to fear of imminent epidemics that have
Global Veterinary Vaccines Market, By Technology Type (Inactivated Vaccines, Tox …
Veterinary/Animal Vaccines – Ensure good health of human’s best friends Veterinary vaccination enhances the health of animals, thus improving their life expectancies. Most common veterinary vaccines include those for rabies, E. coli, distemper, hepatitis rotavirus, parvovirus, brucellosis, and pinkeye. Various diseases such as foot-and-mouth disease and influenza adversely affect livestock across the globe. Economic losses due to death of livestock is significant as it impacts the supply of dairy products, meat,